文献速递生殖医学

Dobbs裁决前、裁决泄露后及最终裁决后非整倍体植入前遗传学检测使用趋势

Trends in use of preimplantation genetic testing for aneuploidy before Dobbs, after Dobbs leak, and after Dobbs final ruling.
PubMed 文献 · Fertil Steril · 2025-02-15

这项回顾性队列研究分析了2021年6月至2023年6月六个州大型生育网络中22488个IVF周期,比较Dobbs裁决前、泄露后及最终裁决后PGT-A使用比例。主要结局PGT-A使用率在三个时期无差异(57.2%、56.8%、56.2%),调整混杂因素后仍无差异;保护性立法州在最终裁决后略有下降(RR 0.96,95%CI 0.93-0.99),限制性州总体使用率更高(66.8% vs 52.4%)。

要点

  • Dobbs裁决前、泄露后及最终裁决后PGT-A使用率分别为57.2%、56.8%、56.2%,无差异。
  • 按年龄和社会经济地位分层,Dobbs裁决与PGT-A使用无关联。
  • 保护性立法州最终裁决后PGT-A使用略降(RR 0.96,95%CI 0.93-0.99)。

核心结论

  • Dobbs裁决时间与患者进行PGT-A无关联,但限制性州在所有纳入时间段PGT-A使用更常见。

研究设计与样本

  • 回顾性队列研究,纳入2021年6月至2023年6月六个州大型生育网络中22488个IVF周期。
  • PGT-A周期定义为至少一个胚胎活检的周期。
  • 按周期开始日期分组:Dobbs裁决前9371个周期,泄露后1581个周期,最终裁决后11536个周期。

主要发现

  • 主要结局PGT-A使用比例在三个时期无差异:裁决前57.2%,泄露后56.8%,最终裁决后56.2%,调整混杂因素后仍无差异。
  • 按年龄和社会经济地位分层,Dobbs裁决与PGT-A使用无关联。
  • 保护性立法州在最终裁决后PGT-A使用略有下降(风险比0.96,95%CI 0.93-0.99)。
  • 限制性州PGT-A总体使用率(66.8%)高于保护性州(52.4%),基于Guttmacher研究所保护性与限制性分类。
  • 各时期年龄、体重指数、抗苗勒管激素、产次及每周期获胚数相似,但种族和不孕诊断存在差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if the use of preimplantation genetic testing for aneuploidy (PGT-A) increased after the Dobbs decision leak on May 2, 2022, and after the Dobbs final ruling on June 24, 2022, compared with before the Dobbs decision. DESIGN: Retrospective cohort study. SUBJECTS: Patients who underwent in vitro fertilization (IVF) within a large fertility network geographically distributed across six states from June 2021 through June 2023. Preimplantation genetic testing for aneuploidy cycles were defined as cycles with at least one embryo biopsied. EXPOSURE: In vitro fertilization cycles were grouped by cycle start date. Cycles starting between May 3, 2022 and June 24, 2022 were considered post-Dobbs leak. These were compared with cycles starting within the year leading up to the leak and those starting within the year after the final ruling. MAIN OUTCOME MEASURES: Percentage of cycles utilizing PGT-A, defined as the number of IVF cycles utilizing PGT-A divided by the total number of IVF cycles during the study period. We stratified by age, socioeconomic status, and state abortion access legislation. RESULTS: We analyzed 9,371 IVF cycles before Dobbs, 1,581 IVF cycles after Dobbs leak, and 11,536 IVF cycles after Dobbs final ruling, totaling 22,488 IVF cycles. Age, body mass index, antimüllerian hormone, parity, and number of embryos obtained per cycle were similar across time periods, but differences existed among race and infertility diagnoses. There were no differences in the primary outcome of the percentage of cycles utilizing PGT-A between study time periods (57.2% pre-Dobbs, 56.8% post-Dobbs leak, 56.2% post-Dobbs final ruling); a finding which remained when adjusting for confounders. There was no association between the Dobbs decision and PGT-A use in subgroups stratified by age and socioeconomic status. A slight decrease in PGT-A use was noted in states with protective abortion legislation after the Dobbs final ruling (risk ratio, 0.96; 95% confidence interval, 0.93-0.99), with overall PGT-A use higher in states with restrictive policies (66.8%) than protective states (52.4%) across all time periods using Guttmacher's Institute's protective vs. restrictive classifications. CONCLUSION: There is no association between Dobbs decision timing and patients' pursuit of PGT-A, but PGT-A use was more common in restrictive states across all included time periods.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Hunkler K, Boedeker D, Flannagan K, et al. Trends in use of preimplantation genetic testing for aneuploidy before Dobbs, after Dobbs leak, and after Dobbs final ruling. Fertil Steril. 2025. PMID: 39961385. doi:10.1016/j.fertnstert.2025.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。